0.7160
-0.0540
(-7.01%)
As of 9:59:02 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 2 | 2 |
| Avg. Estimate | 6.2M | 11M | 38.97M | 30M |
| Low Estimate | -- | 11M | 32.6M | -- |
| High Estimate | 12.4M | 11M | 45.33M | 60M |
| Year Ago Sales | 73.52M | 9.27M | 103.78M | 38.97M |
| Sales Growth (year/est) | -91.57% | 18.70% | -62.45% | -23.01% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 2HA.F | -- | -- | -- | -- |
| S&P 500 | 13.78% | 8.04% | 13.14% | 14.09% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/30/2025 |
| Downgrade | Evercore ISI Group: Outperform to In-Line | 12/20/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/2/2024 |
| Downgrade | TD Cowen: Buy to Hold | 11/18/2024 |
| Reiterates | Cantor Fitzgerald: Overweight | 11/15/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/4/2024 |